ORIGINAL ARTICLES

Subchronic Toxicity of Hydroethanolic Extract of Azanza garckeana Fruit in Wistar Rats

Akinsola Olubiyi 1, 2
Prof. Ojezele M.O
Prof. Eduviere A.T
Celestine Ogheneruro Akpovwre

1Redeemers university

2Redeemer's University

DOI: 10.4314/ajtmbr.v9i1.%x
Published: July 31, 2026

Abstract

Introduction: The fruit of Azanza garckeana is widely consumed in tropical Africa and is traditionally used to treat conditions such as dyslipidemia, oxidative stress, and infertility. Despite its established ethnomedicinal value and promising pharmacological properties, the long-term safety profile of its hydroethanolic extract (AZG-HE) remains insufficiently studied.

Materials and Methods: This study evaluated the safety of repeated oral administration of AZG-HE in albino Wistar rats (n=84) across multiple dose levels over extended treatment periods. Hematological, serum biochemical, and antioxidant parameters were assessed, including lipid profiles, renal and hepatic function markers, and oxidative stress indicators in selected organs. A recovery phase followed treatment to evaluate the reversibility of any observed effects.

Results: Administration of AZG-HE did not result in clinical signs of toxicity, even at the highest tested dose over the longest treatment period. While minor and transient reductions in weight gain and feed intake occurred at higher doses, these normalized by the end of the study. The extract significantly improved lipid profiles in a dose-dependent manner and markedly enhanced antioxidant status, increasing hepatic and renal glutathione and superoxide dismutase activity while reducing lipid peroxidation. All biochemical and physiological changes were fully reversible upon discontinuation of treatment.

Conclusion: Long-term oral administration of Azanza garckeana hydroethanolic extract (AZG-HE) demonstrated a favorable safety profile, with no evidence of cumulative toxicity and complete reversibility of transient effects. Its hypolipidemic and antioxidant activities support its traditional use and potential as a nutraceutical for managing metabolic and oxidative stress-related disorders. Further histopathological and clinical investigations are recommended.

Keywords

Subchronic chronic toxicity Azanza garckeana hypolipidemic antioxidant reversibility
database

Data Availability

Available on request 

Author Biographies

AO

Akinsola Olubiyi

Redeemers university, Redeemer's University

Pharmacology and Lecturer II

MO

Prof. Ojezele M.O

Pharmacology and Professor

AE

Prof. Eduviere A.T

Pharmacology  and Professor  

CA

Celestine Ogheneruro Akpovwre

Pharmacology and Lecturer II

menu_book References

  1. 1. Gadzama US, Muhammad MJ, Ali M. Assessment of nutritional value of Azanza garckeana (Goron Tula/Apple Snot) in Maiduguri Metropolis. Int J Converg Inform Sci Res. 2024 Dec 31;6(9).
  2. 2. Mwove J. Potential for development of novel food products from Azanza garckeana tree fruit: a review. Int J Food Stud. 2021;10:SI121-32
  3. 3. Zakawa NN, Yusuf CS, Oyebanji EO, Timon D, Isa A, Bala U, et al. Anti-microbial activities and phytochemical screening of aqueous fruit pulp extracts of Azanza garckeana (F.Hoffm.). Niger J Bot. 2021;34(1). doi: 10.4314/njbot.v34i1.8.
  4. 4. Bioltif YE, Edward NB, Tyeng TD. A chemical overview of Azanza garckeana. Biol Med Nat Prod Chem. 2020;9(2):91-5. doi: 10.14421/biomedich.2020.92.91-95.
  5. 5. Ochokwu IJ, Dasuki A, Oshoke JO. Azanza garckeana (Goron Tula) as an edible indigenous fruit in north eastern part of Nigeria. J Biol Agric Healthc. 2015;5(15):26-31.
  6. 6. Lawal B, Sani S, Onikanni AS, Ibrahim YO, Agboola AR, Lukman HY, et al. Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of its major phytoconstituents. Biomed Pharmacother. 2022;152:113196. doi: 10.1016/j.biopha.2022.113196.
  7. 7. Maroyi A. Azanza garckeana fruit tree: phytochemistry, pharmacology, nutritional and primary healthcare applications as herbal medicine: a review. Res J Med Plants. 2017;11:115-123.
  8. 8. Laz-Okenwa JOA, Amah-Tariah FS, Ojeka SO. Changes in reproductive hormones levels following administration of hydroethanolic extract of Azanza garckeana fruit in cadmium chloride exposed female Wistar rats. Arch Curr Res Int. 2024;24(5):280-7. doi: 10.9734/acri/2024/v24i5703.
  9. 9. Michael KG, Onyia L, Jidauna SB. Evaluation of phytochemicals in Azanza garckeana (Goron tula) seed. IOSR IOSR J Agric Vet Sci. 2015;10(8):71-4. doi: 10.9790/2380-08517174.
  10. 10. Nkwocha CC, Ogah FJ, Lomi OM, Ale BA. Phytochemical screening and GC-FID identification of bioactive compounds in n-hexane, ethylacetate and methanol fractions of methanolic leaves extract of Azanza garckeana. Food Chem Adv. 2024;4:100712. doi: 10.1016/j.focha.2024.100712.
  11. 11. Nechchadi H, Nadir Y, Benhssaine K, Alem C, Sellam K, Boulbaroud S, et al. Hypolipidemic activity of phytochemical combinations: a mechanistic review of preclinical and clinical studies. Food Chem. 2024;459:140264. doi: 10.1016/j.foodchem.2024.140264.
  12. 12. Olorundare O, Adeneye A, Akinsola A, Kolo P, Agede O, Soyemi S, et al. Irvingia gabonensis seed extract: an effective attenuator of doxorubicin-mediated cardiotoxicity in Wistar rats. Oxid Med Cell Longev. 2020;2020:1602816. doi: 10.1155/2020/1602816
  13. 13. Williams ET, Ambrose S, Timothy N. Assessment of nutritional composition of Azanza garckeana (Goron Tula) seed in Gombe, Nigeria. Int J Innov Sci Eng Technol. 2020;7(11):213-222
  14. 14. Sirajo K, Shehu Z, Binanci MU, Mas’ud I, Diri AA. Study of proximate composition of seed and peel of (Azanza garckeana) goron tula. Asian J Food Res Nutr. 2022;1(2):76-81. https://journalajfrn.com/index.php/AJFRN/article/view/11
  15. 15. Japhet CP, Comfort Philip, Carrol Domkat Luka, Ishaya Yohanna Longdet. Exploring the antidiabetic potential of Azanza garckeana parts on streptozotocin induced diabetic rats. Asian J Biochem Genet Mol Biol. 2025;17(5):26-36. doi:10.9734/ajbgmb/2025/v17i5465
  16. 16. Ibrahim P, Abdurahman EM, Bisallah M. Pharmacognostic evaluation of the leaves of Azanza garckeana (F. Hoffm.) Exell et Hillc. (Malvaceae). J Pharm Bioresources. 2019;16(2):125-32. doi:10.4314/jpb.v16i2.5
  17. 17. Mshelia EH, Watirahyel EM, Maigari AU, Yohanna C, Ismail F. Cytotoxicity and antioxidant activity of stem bark extracts of Azanza garckeana (kola of Tula). Eur J Pure Appl Chem. 2016;3(2):16-24
  18. 18. Hassan AI, Aminu AI. Evaluation of the Antimicrobial Activity and Toxicity of Local and Foreign Seeds of Azanza garckeana (Goron Tula) Extracts. UMYU Journal of Microbiology Research (UJMR). 2024;9(1):1-14. doi:10.47430/ujmr.2491.001
  19. 19. Ibrahim M, Idoko AS, Ganiyu AI. Evaluation of the acute and sub-acute toxicity of Azanza garckeana aqueous leaves extract in Wistar rats. Niger J Biochem Mol Biol. 2024;39(1):8-15. doi: 10.4314/njbmb.v39i1.2.
  20. 20. Jităreanu A, Trifan A, Vieriu M, Caba IC, Mârțu I, Agoroaei L. Current Trends in Toxicity Assessment of Herbal Medicines: A Narrative Review. Processes. 2023;11(1):83. doi:10.3390/pr11010083
  21. 21. Iloabuchi GC, Idoko AS, Ganiyu AI, Hannafi AM, Umar S. Effects of Azanza garckeana Fruit Pulp on Metabolic Syndrome in Wistar Rats Fed on High Fructose Diet. UMYU Journal of Microbiology Research (UJMR). 2024;9(1):55-64. doi:10.47430/ujmr.2491.006
  22. 22. Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 2016;31(8):984-991. doi:10.1093/heapol/czw022.
  23. 23. Agunbiade OS, Ojezele OM, Ojezele JO, Ajayi AY. Hypoglycaemic activity of Commelina africana and Ageratum conyzoides in relation to their mineral composition. Afr Health Sci. 2012 Jun;12(2):198-203. doi: 10.4314/ahs.v12i2.19
  24. 24. Olorundare OE, Adeneye AA, Akinsola AO, Sanni DA, Koketsu M, Mukhtar H. Clerodendrum volubile Ethanol Leaf Extract: A Potential Antidote to Doxorubicin-Induced Cardiotoxicity in Rats. J Toxicol. 2020 Jul 4;2020:8859716. doi: 10.1155/2020/8859716.
  25. 25. Okaiyeto K, Oguntibeju OO. African herbal medicines: adverse effects and cytotoxic potentials with different therapeutic applications. Int J Environ Res Public Health. 2021;18(11):5988. doi:10.3390/ijerph18115988.
  26. 26. Ahmad MH, Zezi AU, Anafi SB, Alshargi OY, Mohammed M, Mustapha S, et al. Sub-acute toxicity study on hydromethanolic leaves extract of Combretum hypopilinum (Combretaceae) Diels in Wistar rats. Toxicol Res. 2022;38(4):487-502. doi: 10.1007/s43188-022-00133-5.
  27. 27. Hoffman WP, Ness DK, van Lier RB. Analysis of rodent growth data in toxicology studies. Toxicol Sci. 2002 Apr;66(2):313-9. doi: 10.1093/toxsci/66.2.313.
  28. 28. Flanagan EW, Spann R, Berry SE, Berthoud HR, Broyles S, Foster GD, et al. New insights in the mechanisms of weight-loss maintenance: summary from a Pennington symposium. Obesity (Silver Spring). 2023;31(12):2895-2908. doi:10.1002/oby.23905.
  29. 29. Tucci SA. Phytochemicals in the control of human appetite and body weight. Pharmaceuticals (Basel). 2010;3(3):748-763. doi:10.3390/ph3030748.
  30. 30. Cosme F, Aires A, Pinto T, Oliveira I, Vilela A, Gonçalves B. A comprehensive review of bioactive tannins in foods and beverages: functional properties, health benefits, and sensory qualities. Molecules. 2025;30(4):800. doi:10.3390/molecules30040800
  31. 31. Mohammed AH, Mshelia EH, Watirahyel EM, Christopher Y. Phytochemicals Screening and Antimicrobial Activity of the Stem Bark Extracts of Azanza garckeana (Kola of Tula). Sch Int J Tradit Complement Med. 2021;4(6):122-127. doi:10.36348/sijtcm.2021.v04i06.010
  32. 32. Ushie OA, Iyen IS, Aasegh TJ, Ama SO, Aikhoje EF, Shamaki HA. Phytochemical screening and antimicrobial activities of hexane extract of Azanza garckeana. Res J Pharm Chem Biol Sci (RJPCBS). 2022;3(2):7-12. doi:10.5281/zenodo.6667091
  33. 33. Cui MT, Liang ZW, Sun YZ, Wu J, Lu H, Wang WJ, et al. The prognostic roles of red blood cell-associated indicators in patients with resectable gastric cancers. Transl Cancer Res. 2020;9(4):2300-2311. doi:10.21037/tcr.2020.03.46.
  34. 34. Lewis RW, Billington R, Debryune E, Gamer A, Lang B, Carpanini F. Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Pathol. 2002;30(1):66-74. doi:10.1080/01926230252824725.
  35. 35. Baldrick P, Cosenza ME, Alapatt T, Bolon B, Rhodes M, Waterson I. Toxicology paradise: sorting out adverse and non-adverse findings in animal toxicity studies. Int J Toxicol. 2020;39(5):365-378. doi:10.1177/1091581820935089.
  36. 36. Ugwu GN, Ugorji CO, Berebon DP, Chinwuba P, Onyesife CO, Amattah WO, Ezigbo MM. Phytoconstituents, acute toxicity and the effect of methanol extract of Azanza garckeana (Malvaceae) on the haematological indices of adult Wistar rats. Afr J Pharm Res Dev. 2024;16(3):117-129. doi:10.59493/ajopred/2024.3.13
  37. 37. Kanta E, Musalwa-Muyangwa S, Rehana O, Prashar L. Acute and sub-acute toxicity of methanol root extract of Azanza garckeana (Malvaceae) in albino rats. Med J Zambia. 2025;52(4):497-510.
  38. 38. Ali KM, Wonnerth A, Huber K, Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities. Br J Pharmacol. 2012;167(6):1177-1194. doi:10.1111/j.1476-5381.2012.02081.x
  39. 39. Nagao M, Nakajima H, Toh R, Hirata KI, Ishida T. Cardioprotective effects of high-density lipoprotein beyond its anti-atherogenic action. J Atheroscler Thromb. 2018;25(10):985-993. doi:10.5551/jat.RV17025.
  40. 40. Oyagbemi AA, Omobowale TO, Azeez IO, Abiola JO, Adedokun RAM, Nottidge HO. Toxicological evaluations of methanolic extract of Moringa oleifera leaves in liver and kidney of male Wistar rats. J Basic Clin Physiol Pharmacol. 2013;24(4):307-312. doi:10.1515/jbcpp-2012-0061.
  41. 41. Ahmad MH, Zezi AU, Anafi SB, Alshargi OY, Mohammed M, Mustapha S, et al. Subacute toxicity study on hydromethanolic leaves extract of Combretum hypopilinum (Combretaceae) Diels in Wistar rats. Toxicol Res. 2022;38(4):487-502. doi:10.1007/s43188-022-00133-5.
  42. 42. Duru EI, Nwankwo CE. Impact of hydro-methanolic seed extract of Azanza garckeana on lipid profiles and oxidative stress in male Wistar rats. Ayden Int J Biomed Res Technol. 2024;12(3):10-15. https://doi.org/10.5281/zenodo.13829408
  43. 43. Yusuf A, Lawal B, Alozieuwa U, Onikanni A, Lukman H, Fadaka AO, et al. Attenuating effects of Azanza garckeana fractions on glycemo-impaired-associated dyslipidemia, hepatopathy, and nephropathy. Am J Transl Res. 2023;15(10):5997-6014.
  44. 44. Velissaridou A, Panoutsopoulou E, Prokopiou V, Tsoupras A. Cardio-protective-promoting properties of functional foods inducing HDL-cholesterol levels and functionality. Nutraceuticals. 2024;4(4):469-502. doi:10.3390/nutraceuticals4040028.
  45. 45. Hall P, Cash J. What is the real function of the liver 'function' tests? Ulster Med J. 2012;81(1):30-6.
  46. 46. Afolabi SO, Olorundare O, Akanbi OB, Bello MK, Njan A, Agede OA, et al. GC/MS analysis and a 30-day toxicological evaluation of a Nigerian immunomodulatory polyherbal supplement (PHS). Pharmacol Toxicol Nat Med. 2023;3(2):1-14. doi: 10.52406/ptnm.v3i2.70.
  47. 47. Umana IK, Tochuckwu TA, Ehigiator BE, Ikem CJ, Udom GJ, Akinsola AO. Toxicity and antioxidant assessment of ethanol leaf extract of Hibiscus surattensis in Wistar rats: hepatotoxicity evaluation. Afr J Pharm Res Dev. 2024;16(3):25-31.
  48. 48. Alamri ZZ. The role of liver in metabolism: an updated review with physiological emphasis. Int J Basic Clin Pharmacol. 2018;7(11):2271-2276. doi:10.18203/2319-2003.ijbcp20184211.
  49. 49. Vaja R, Rana M. Drugs and the liver. Anaesth Intensive Care Med. 2020;21(10):517-523. doi:10.1016/j.mpaic.2020.07.001.
  50. 50. Weber S, Allgeier J, Denk G, Gerbes AL. Marked increase of gamma-glutamyltransferase as an indicator of drug-induced liver injury in patients without conventional diagnostic criteria of acute liver injury. Visc Med. 2022;38(3):223-8. doi: 10.1159/000519752.
  51. 51. Salazar JH. Overview of urea and creatinine. Lab Med. 2014;45(1):e19-20. doi: 10.1309/LM920SBNZPJRJGUT.
  52. 52. Xu X, Zeng T, Chen S, Tian N, Zhang C, Chen Y, et al. Acute kidney injury: pathogenesis and therapeutic interventions. Mol Biomed. 2025;6(1):61. doi: 10.1186/s43556-025-00293-4.
  53. 53. Lin W. Clinical significance of serum creatinine, urea nitrogen and uric acid levels in patients with chronic renal failure. Int J Biol Life Sci. 2023;3(3):19-26. doi: 10.54097/ijbls.v3i3.04.
  54. 54. Madhavan H, Nobel MM, Rajalakshmi M, Kulkarni S, Thomas TRA, Shalini B, et al. Sociodemographic features, serum urea, creatinine and blood urea nitrogen/creatinine ratio in chronic kidney disease patients – a record based retrospective study. Glob Journal Health Sci Res. 2024;2:82-5. doi: 10.25259/GJHSR_8_2024.
  55. 55. Shrimanker I, Bhattarai S. Electrolytes. Treasure Island (FL): StatPearls Publishing; 2025.
  56. 56. Nurudeen QO, Asinmi MR, Falana MB, Dikwa MA, Yusuf ZM, Lambe MO. Antioxidant activity and toxicological implications of the aqueous extract of Azanza garckeana fruit pulp in female Wistar rats. Niger J Biochem Mol Biol. 2024;39(1):1-7.
  57. 57. Yusuf AA, Mohammed BA, Abafi MJ, Garba R, Usman OM, Ibrahim J, Ariyeloye DS, Berinyuy EB. Alterations in serum urea, creatinine and electrolytes concentrations in Wistar rats following repeated administration of methanol extracts of Azanza garckeana pulp. Sch Int J Biochem. 2020;3(6):127-131. https://doi.org/10.36348/sijb.2020.v03i06.002
  58. 58. Alozieuwa UB, Lawal D, Sani S, Onikanni AS, Osuji O, Ibrahim YO, et al. Luteolin-rich extract of Thespesia garckeana (snot apple) contains potential drug-like candidates and modulates glycemic and oxidoinflammatory aberrations in experimental animals. Oxid Med and Cell Longev. 2022;2022:1215097. doi: 10.1155/2022/1215097.
  59. 59. Lawal B, Kuo YC, Onikanni SA, Chen YF, Abdulrasheed-Adeleke T, Fadaka AO, Olugbodi JO, Lukman HY, Olawale F, Mahmoud MH, Batiha GE, Wu AT, Huang HS. Computational identification of novel signature of T2DM-induced nephropathy and therapeutic bioactive compounds from Azanza garckeana. Am J Transl Res. 2023 Jul 15;15(7):4504-4520
  60. 60. Ojezele OJ, Ojezele MO, Adeosun AM. Comparative phytochemistry and antioxidant activities of water and ethanol extract of Annona muricata Linn leaf, seed and fruit. Adv Biol Res. 2016;10(4):230-5. doi: 10.5829/idosi.abr.2016.10.4.10514.
  61. 61. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 2018;54(4):287-93. doi: 10.1016/j.ajme.2017.09.001.
  62. 62. Ozbek E. Induction of oxidative stress in kidney. Int J Nephrol. 2012;2012:465897. doi: 10.1155/2012/465897.
  63. 63. Chandimali N, Bak SG, Park EH, Lim HJ, Won YS, Kim EK, et al. Free radicals and their impact on health and antioxidant defenses: a review. Cell Death Discov. 2025;11:19. doi: 10.1038/s41420-024-02278-8.
  64. 64. Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K. Oxidative stress in liver pathophysiology and disease. Antioxidants (Basel). 2023;12(9):1653. doi: 10.3390/antiox12091653.
  65. 65. Manful CF, Fordjour E, Subramaniam D, Sey AA, Abbey L, Thomas R. Antioxidants and reactive oxygen species: shaping human health and disease outcomes. Int J Mol Sci. 2025;26(15):7520. doi: 10.3390/ijms26157520.
  66. 66. Zheng M, Liu Y, Zhang G, Yang Z, Xu W, Chen Q. The applications and mechanisms of superoxide dismutase in medicine, food, and cosmetics. Antioxidants (Basel). 2023;12(9):1675. doi: 10.3390/antiox12091675.
  67. 67. Maurya RP, Prajapat MK, Singh VP, Roy M, Todi R, Bosak S, et al. Serum malondialdehyde as a biomarker of oxidative stress in patients with primary ocular carcinoma: impact on response to chemotherapy. Clin Ophthalmol. 2021;15:871-9. doi: 10.2147/OPTH.S287747.
download View/Download PDF

Published in Vol. 9 No. 1: African Journal of Tropical Medicine and Biomedical Research, July 2026

7
Views
3
Downloads
67
Citations

format_quote How to Cite

1.
Olubiyi A, Ojezele MO, Eduviere AT, Akpovwre CO. Subchronic Toxicity of Hydroethanolic Extract of Azanza garckeana Fruit in Wistar Rats. Afr. J. Trop. Med. Biomed. Res. [Internet]. 2026 Jul. 31 [cited 2026 Aug. 27];9(1):29-76. Available from: https://www.ajtmbr.org.ng/index.php/home/article/view/azanza-subchronic-toxicity
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

Share this Article

policy

Copyright (c) 2026 African Journal of Tropical Medicine and Biomedical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

r